Article
Evaluation of INK4A promoter methylation using pyrosequencing and circulating cell-free DNA from patients with hepatocellular carcinoma.
Clinical chemistry and laboratory medicine - 1 Jun 2014
Huang Gengming, Krocker Joseph D, Kirk Jason L, Merwat Shehzad N, Ju Hyunsu, Soloway Roger D, Wieck Lucas R, Li Albert, Okorodudu Anthony O, Petersen John R, Abdulla Nihal E, Duchini Andrea, Cicalese Luca, Rastellini Cristiana, Hu Peter C, Dong Jianli
Abstract excerpt
BACKGROUND: Hyper-methylation of CpG dinucleotides in the promoter region of inhibitor of cyclin-dependent kinase 4A (INK4A) has been reported in 60%-80% of hepatocellular carcinoma (HCC). As INK4A promoter hypermethylation event occurs early in HCC progression, the quantification of INK4A promoter methylation in blood sample may represent a useful biomarker for non-invasive diagnosis and prediction of response...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
